Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
KSK Corporation and Hitachi, Ltd. have begun a collaborative creation project to…
NTT Technocross Corporation will begin offering "HM-neo academic," a university-optimized version of…
Ubie Inc. aims to 'use technology to guide people to appropriate medical…
PHC Holdings Corporation and its subsidiary Ascensia Diabetes Care, a global diabetes…
Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics…
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the two…
Hitachi Systems, Ltd., Kanagawa Prefecture, MedMirai Co., Ltd., and the University of…
アカウントにサインインする